Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

150 ARTÍCULOS , VIENDO DEL 106 AL 120

Serotonin toxicity: a short review of the literature and two case reports involving citalopram

Talarico G, Tosto G, Pietracupa S, Piacentini E, Canevelli M, Lenzi GL, Bruno G.

Neurol Sci. 2011 Jun;32(3):507-9. doi: 10.1007/s10072-011-0546-z. Epub 2011 Apr 14.

Cerebellar ataxia: pathophysiology and rehabilitation

Marsden J, Harris C.

Clin Rehabil. 2011 Mar;25(3):195-216. doi: 10.1177/0269215510382495.

[Cockayne syndrome]

Wang XM, Cui YP, Liu YF, Wei L, Liu H, Wang XL, Zheng ZZ.

Zhongguo Dang Dai Er Ke Za Zhi. 2011 Feb;13(2):141-4.

Therapeutics for multiple sclerosis symptoms

Ben-Zacharia AB.

Mt Sinai J Med. 2011 Mar-Apr;78(2):176-91. doi: 10.1002/msj.20245.

Acute VI nerve palsy in a 4 year-old girl with Chiari I malformation and pontomedullary extension of syringomyelia: case report and review of the literature

Massey SL, Buland J, Hauber S, Piatt J Jr, Goraya J, Faerber E, Valencia I.

Eur J Paediatr Neurol. 2011 Jul;15(4):303-9. doi: 10.1016/j.ejpn.2011.04.001. Epub 2011 May 10.

Autosomal recessive spastic ataxia of Charlevoix-Saguenay: compound heterozygotes for nonsense mutations of the SACS gene

Narayanan V, Rice SG, Olfers SS, Sivakumar K.

J Child Neurol. 2011 Dec;26(12):1585-9. doi: 10.1177/0883073811412825. Epub 2011 Jul 10.

Co-segregation of Huntington disease and hereditary spastic paraplegia in 4 generations

Panas M, Karadima G, Kalfakis N, Vassilopoulos D.

Neurologist. 2011 Jul;17(4):211-2. doi: 10.1097/NRL.0b013e3182173567.

New trends in the science of botulinum toxin-A as applied in dystonia

Pickett A, Rosales RL.

Int J Neurosci. 2011;121 Suppl 1:22-34. doi: 10.3109/00207454.2010.539306. Epub 2011 Jan 19.

Two patients with clinically distinct manifestation of pyruvate dehydrogenase deficiency due to mutations in PDHA1 gene

Magner M, Vinšová K, Tesařová M, Hájková Z, Hansíková H, Wenchich L, Ješina P, Smolka V, Adam T, Vaněčková M, Zeman J, Honzík T.

Prague Med Rep. 2011;112(1):18-28.

A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome

Ito Y, Oguni H, Ito S, Oguni M, Osawa M.

Dev Med Child Neurol. 2011 Jul;53(7):658-63. doi: 10.1111/j.1469-8749.2011.03961.x. Epub 2011 Apr 18.

NIPA1 mutation in complex hereditary spastic paraplegia with epilepsy

Svenstrup K, Møller RS, Christensen J, Budtz-Jørgensen E, Gilling M, Nielsen JE.

Eur J Neurol. 2011 Sep;18(9):1197-9. doi: 10.1111/j.1468-1331.2011.03359.x. Epub 2011 Feb 22.

Prolonged episode of dystonia and dyskinesia resembling status epilepticus following acute intrathecal baclofen withdrawal

Specchio N, Carotenuto A, Trivisano M, Cappelletti S, Vigevano F, Fusco L.

Epilepsy Behav. 2011 Jul;21(3):321-3. doi: 10.1016/j.yebeh.2011.04.052. Epub 2011 May 24.

Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review

Pin TW, McCartney L, Lewis J, Waugh MC.

Dev Med Child Neurol. 2011 Oct;53(10):885-95. doi: 10.1111/j.1469-8749.2011.03992.x. Epub 2011 Jun 3.

Botulinum toxin A (Dysport®): in dystonias and focal spasticity

Keam SJ, Muir VJ, Deeks ED.

Drugs. 2011 May 28;71(8):1043-58. doi: 10.2165/11206340-000000000-00000.

Botulinum Toxin in the management of hitchhiker's toe

Gaber TA, Basu B, Shakespeare D, Singh R, Salam S, McFarlane J.

NeuroRehabilitation. 2011;28(4):395-9. doi: 10.3233/NRE-2011-0669.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias